CRYO CELL INTERNATIONAL INC
For the period ended Nov 30, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
CCEL$4.87-0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
| Exhibit No. | Description |
| 3.1 (1) | Amended and Restated Certificate of Incorporation |
| 3.2 (2) | Amended and Restated By-Laws |
| 10.6 (3) | Secondary Storage Agreement with Safti-Cell, Inc. dated October 1, 2001 |
| 10.7 (3) | Addendum Agreement dated November 2001 to Secondary Storage Agreement with Safti-Cell, Inc. |
| 10.9 (4) | Lease Agreement dated April 15, 2004 between Brooker Creek North, LLP and the Company |
| 10.10 (5) | Employment Agreement with Mercedes Walton, dated August 15, 2005 |
| 10.11 (6) | Employment Agreement with Jill M. Taymans dated November 1, 2005. |
| 10.12 (6) | Forms of Stock Option Agreements under 2000 Stock Incentive Plan. |
| 10.13 (7) | First Lease Amendment by and between the Company and Brooker Creek North I, LLP, dated June 7, 2006. |
| 10.14 (8) | 2006 Stock Incentive Plan |
| 10.15 (9) | Employment Agreement dated April 1, 2007 between the Company and Julie Allickson |
| 10.16 (10) | Agreement dated June 4, 2007 by and among the Company and Andrew J. Filipowski, the Andrew J. Filipowski Revocable Trust and Matthew G. Roszak |
| 10.17 (11) | Agreement dated January 24, 2008 by and among the Company and Andrew J. Filipowski, the Andrew J. Filipowski Revocable Trust, Matthew G. Roszak and SilkRoad Equity LLC |
| 10.18 (11) | Agreement dated January 24, 2008 by and among the Company and Ki Yong Choi and the UAD 7/21/01 FBO Choi Family Living Trust |
| 10.20 (12) | Amendment dated July 16, 2007, amending Employment Agreement with Mercedes Walton, dated August 15, 2005 |
| 10.21 (13) | Amendment dated July 18, 2008, amending Employment Agreement with Mercedes Walton, dated August 15, 2005 |
| 10.22 (13) | Amendment dated July 18, 2008, amending Employment Agreement with Jill M. Taymans, dated November 1, 2005 |
| 10.23 (14) | 2000 Stock Incentive Plan |
| 10.24 (14) | Amendment to 2000 Stock Incentive Plan dated April 6, 2004 |
| 10.25 (14) | Amendment to 2000 Stock Incentive Plan dated August 14, 2008 |
| 10.26 (12) | Stipulation and Order of Court of Chancery of the State of Delaware dated June 18, 2008 |
| 10.27 (15) | Employment Agreement with David Portnoy dated December 1, 2011 |
| 10.28 (15) | Employment Agreement with Mark Portnoy dated December 1, 2011 |
| 10.29 (16) | Amendment dated, February 13, 2012, amending Employment Agreement with David Portnoy |
| 10.30 (16) | Amendment dated, February 13, 2012, amending Employment Agreement with Mark Portnoy |
| 10.31 (17) | Employment Agreement with Oleg Mikulinsky dated March 5, 2012 |
| 10.32 (18) | Amendment dated May 1, 2013, amending Employment Agreement with Oleg Mikulinsky dated March 5, 2012 |
| 10.33 (19) | Employment Agreement with David Portnoy dated December 1, 2013 |
| 10.34 (19) | Employment Agreement with Mark Portnoy dated December 1, 2013 |
| 10.35 (20) | Employment Agreement with Linda Kelley dated June 18, 2012 |
| 10.36 (20) | Amendment dated October 29, 2013, amending Employment Agreement with Linda Kelley dated June 18, 2012 |
| 10.37 (21) | Certificate of Designation of Series A Junior Participating Preferred Stock of Cryo-Cell International, Inc. |
| 10.38 (22) | Asset Purchase Agreement by and between Cytomedical Design Group LLC and Cryo-Cell International, Inc. dated June 15, 2015 |
| 10.39 (21) | Rights Agreement dated December 5, 2014 |
| 10.40 (23) | Amendment No. 1 to Asset Purchase Agreement dated June 30, 2015 |
| 10.41 (24) | Third Lease Amendment by and between the Company and EJB Brooker Creek, LLC., dated January 12, 2016. |
| 10.42 (25) | Amended and Restated Employment Agreement with David Portnoy dated December 1, 2015 |
| 10.43 (25) | Amended and Restated Employment Agreement with Mark Portnoy dated December 1, 2015 |
| 10.44 (26) | Amendment Agreement with Oleg Mikulinsky dated December 1, 2015. |
| 10.45 (27) | Stock Purchase Agreement dated June 16, 2016. |
| 10.46 (28) | 2012 Equity Incentive Plan. |
| 10.47 (29) | Amended and restated Employment Agreement with David Portnoy dated March 8, 2018. |
| 10.48 (29) | Amended and restated Employment Agreement with Mark Portnoy dated March 8, 2018. |
| 10.49 (30) | Amended Agreement with Oleg Mikulinsky effective December 1, 2017. |
| 10.50 (31) | Second Amendment to Credit Agreement with Texas Capital Bank dated June 11, 2018. |
| 10.51 (31) | Second Amended and Restated Promissory Note dated June 11, 2018 |
| 10.52 (32) | Retrospective Amendments to the 2000 Stock Incentive Plan |
| 10.53 (32) | Retrospective Amendments to the 2006 Stock Incentive Plan |
| 10.54 (32) | 2012 Amended and Restated Equity Incentive Plan |
| 10.55 (33) | Patent Option Agreement |
| 10.56 (34) | 2020 Employment Agreement for David Portnoy |
| 10.57 (34) | 2020 Employment Agreement for Mark Portnoy |
| 10.58 (35) | 2021 Employment Agreement for Oleg Mikulinsky |
| 10.59 (36)10.60 (37)10.61 (38)10.62 (38) | First Amendment to License Agreement2022 Equity Incentive PlanCredit Agreement among Cryo-Cell International, Inc. and Susser BankAmendment to the Credit Agreement with Susser Bank |
| 10.63 (39) | 2022 Employment Agreement for David Portnoy |
| 10.64 (39) | 2022 Employment Agreement for Mark Portnoy |
| 10.65 (40) | Second Amendment to License Agreement |
| 10.66 (41) | Third Amendment to Credit Agreement |
| 24 | Power of Attorney (included on signature page) |
| 31.1 | Certification of Co-CEO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 31.2 | Certification of Co-CEO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 31.3 | Certification of CFO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 32.1 | Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 97 (41) | Clawback Policy |
| 101.INS | Inline XBRL Instance Document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
| 104 | Cover Page Interactive Date File (embedded within the Inline XBRL document) |
| (1) | Incorporated by reference to the Company’s Quarterly Report on Form 10-QSB for the quarter ended May 31, 2002. |
| (2) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on December 11, 2018. |
| (3) | Incorporated by reference to the Company’s Annual Report on Form 10-KSB for the year ended November 30, 2002. |
| (4) | Incorporated by reference to the Company’s Quarterly Report on Form 10-QSB for the quarter ended May 31, 2004. |
| (5) | Incorporated by reference to the Company’s Quarterly Report on Form 10-QSB filed for the quarter ended August 31, 2005. |
| (6) | Incorporated by reference to the Company’s Annual Report on Form 10-KSB for the year ended November 30, 2005. |
| (7) | Incorporated to the Company’s Quarterly Report on Form 10-QSB for the quarter ended May 31, 2006. |
| (8) | Incorporated by reference to Annex B to the Definitive Proxy Statement filed June 1, 2006. |
| (9) | Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended May 31, 2007. |
| (10) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 8, 2007. |
| (11) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on January 25, 2008. |
| (12) | Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended May 31, 2008. |
| (13) | Incorporated by reference to the Company’s Quarterly Report on Form 10-Q for the quarter ended August 31, 2008. |
| (14) | Incorporated by reference to the Company’s Annual Report on Form 10-KSB for the year ended November 30, 2008. |
| (15) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on December 7, 2011. |
| (16) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on February 17, 2012. |
| (17) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on March 9, 2012 |
| (18) | Incorporated by reference to the Company's Quarterly Report on Form 10-Q for the quarter ended May 31, 2013. |
| (19) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on February 27, 2014. |
| (20) | Incorporated by reference to the Company’s Annual Report on Form 10-K for the year ended November 30, 2013. |
| (21) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on December 3, 2014. |
| (22) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 19, 2015 |
| (23) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on July 16, 2015 |
| (24) | Incorporated by reference to the Company’s Annual Report on Form 10-K for the year ended November 30, 2015 |
| (25) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on April 19, 2016. |
| (26) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on April 20, 2016. |
| (27) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 24, 2016. |
| (28) | Incorporated by reference to Appendix B to the proxy statement for the Annual Meeting of Stockholders of the Company (Commission File No. 000-23386), filed by the Company under the Exchange Act with the Commission on June 21, 2012. |
| (29) | Incorporated by reference to the Company’s Current Report on Form 8-K filed March 13, 2018. |
| (30) | Incorporated by reference to the Company’s Current Report on Form 8-K filed May 24, 2018. |
| (31) | Incorporated by reference to the Company’s Current Report on Form 8-K filed June 15, 2018. |
| (32) | Incorporated by reference the proxy statement for the Annual Meeting of Stockholders of the Company (Commission File No. 000-23386), filed by the Company under the Exchange Act with the Commission on October 29, 2019. |
| (33) | Incorporated by reference to the Company’s Current Report on Form 8-K filed on June 11, 2020. |
| (34) | Incorporated by reference to the Company's Current Report on Form 8-K filed on June 30, 2021. |
| (35) | Incorporated by reference to the Company's Current Report on Form 8-K filed on August 4, 2021. |
| (36) | Incorporated by reference to the Company's Current Report on Form 10-K for the year ended November 30, 2021. |
| (37) | Incorporated by reference to the Company's Current Report on Form 10-Q for the quarter ended February 28, 2022. |
| (38) | Incorporated by reference to the Company's Current Report on Form 10-Q for the quarter ended August 31, 2022. |
| (39) | Incorporated by reference to the Company's Current Report on Form 8-K filed December 29, 2022. |
| (41) | Incorporated by reference to the Company's Current Report on Form 10K filed February 28, 2024. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.